Saturday, May 12, 2018

In a new study, half of cancer doctors recommended cannabis to patients but thanks to government restrictions, have no idea of its benefits

A new study was published on May 10 by the Journal of Clinical Oncology and according to a poll taken of Doctors who deal with cancer in the 29 states where medical marijuana is legal, half of them recommended the drug to their patients while also admitting they didn't have a full understanding of the compounds benefits.

Thanks in large part to the Federal government still keeping Cannabis as a Schedule 1 drug, medical research is extremely limited and unavailable to Doctors seeking to find new ways to aid their patients in both the treatment of, and recovery from, cancer.

Nearly half of U.S. cancer doctors who responded to a survey say they’ve recently recommended medical marijuana to patients, although most say they don’t know enough about medicinal use. 
The results reflect how marijuana policy in some states has outpaced research, the study authors said. All 29 states with medical marijuana programs allow doctors to recommend it to cancer patients. But no rigorous studies in cancer patients exist. That leaves doctors to make assumptions from other research on similar prescription drugs, or in other types of patients. 
“The big takeaway is we need more research, plain and simple,” said Dr. Ilana Braun of Dana-Farber Cancer Institute in Boston, who led the study published Thursday in the Journal of Clinical Oncology. - Leafly 


Post a Comment